199 related articles for article (PubMed ID: 29474087)
21. Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives.
Téllez-Sanz R; García-Fuentes L; Vargas-Berenguel A
Curr Med Chem; 2013; 20(24):2979-90. PubMed ID: 23834183
[TBL] [Abstract][Full Text] [Related]
22. Combined inhibition of autophagy protein 5 and galectin-1 by thiodigalactoside reduces diet-induced obesity through induction of white fat browning.
Parray HA; Yun JW
IUBMB Life; 2017 Jul; 69(7):510-521. PubMed ID: 28444942
[TBL] [Abstract][Full Text] [Related]
23. Endogenous galectins and effect of galectin hapten inhibitors on the differentiation of the chick mesonephros.
Murphy KM; Zalik SE
Dev Dyn; 1999 Jul; 215(3):248-63. PubMed ID: 10398535
[TBL] [Abstract][Full Text] [Related]
24. Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands.
Fischöder T; Laaf D; Dey C; Elling L
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796164
[TBL] [Abstract][Full Text] [Related]
25. Proteomic Identification of Target Proteins of Thiodigalactoside in White Adipose Tissue from Diet-Induced Obese Rats.
Parray HA; Yun JW
Int J Mol Sci; 2015 Jun; 16(7):14441-63. PubMed ID: 26121299
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of glycoprotein-based multivalent glyco-ligands for influenza hemagglutinin and human galectin-3.
Wang H; Huang W; Orwenyo J; Banerjee A; Vasta GR; Wang LX
Bioorg Med Chem; 2013 Apr; 21(7):2037-44. PubMed ID: 23411399
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3.
Ou C; Li C; Feng C; Tong X; Vasta GR; Wang LX
Bioorg Med Chem; 2022 Oct; 72():116974. PubMed ID: 36108470
[TBL] [Abstract][Full Text] [Related]
28. Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3.
Böcker S; Elling L
Bioengineering (Basel); 2017 Apr; 4(2):. PubMed ID: 28952509
[TBL] [Abstract][Full Text] [Related]
29. Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.
Wolfenden M; Cousin J; Nangia-Makker P; Raz A; Cloninger M
Molecules; 2015 Apr; 20(4):7059-96. PubMed ID: 25903363
[TBL] [Abstract][Full Text] [Related]
30. Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.
Masuyer G; Jabeen T; Öberg CT; Leffler H; Nilsson UJ; Acharya KR
FEBS J; 2012 Jan; 279(2):193-202. PubMed ID: 22059385
[TBL] [Abstract][Full Text] [Related]
31. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH
Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897
[TBL] [Abstract][Full Text] [Related]
32. Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells.
Delaine T; Cumpstey I; Ingrassia L; Le Mercier M; Okechukwu P; Leffler H; Kiss R; Nilsson UJ
J Med Chem; 2008 Dec; 51(24):8109-14. PubMed ID: 19053747
[TBL] [Abstract][Full Text] [Related]
33. Lactulose as a novel template for anticancer drug development targeting galectins.
Kishor C; Ross RL; Blanchard H
Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
[TBL] [Abstract][Full Text] [Related]
34. Targeted inhibition of galectin 1 by thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats.
Mukherjee R; Kim SW; Park T; Choi MS; Yun JW
Int J Obes (Lond); 2015 Sep; 39(9):1349-58. PubMed ID: 25920776
[TBL] [Abstract][Full Text] [Related]
35. Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.
Campo VL; Marchiori MF; Rodrigues LC; Dias-Baruffi M
Glycoconj J; 2016 Dec; 33(6):853-876. PubMed ID: 27526114
[TBL] [Abstract][Full Text] [Related]
36. Soluble beta-galactosyl-binding lectin (galectin) from toad ovary: crystallographic studies of two protein-sugar complexes.
Bianchet MA; Ahmed H; Vasta GR; Amzel LM
Proteins; 2000 Aug; 40(3):378-88. PubMed ID: 10861929
[TBL] [Abstract][Full Text] [Related]
37. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants.
Dam TK; Gabius HJ; André S; Kaltner H; Lensch M; Brewer CF
Biochemistry; 2005 Sep; 44(37):12564-71. PubMed ID: 16156668
[TBL] [Abstract][Full Text] [Related]
38. Suppression of SERPINA1-albumin complex formation by galectin-3 overexpression leads to paracrine growth promotion of chronic myelogenous leukemia cells.
Nakayama R; Kuroda J; Taniyama N; Yamamoto-Sugitani M; Wada S; Kiyota M; Mizutani S; Chinen Y; Matsumoto Y; Nagoshi H; Shimura Y; Kobayashi T; Horiike S; Sato K; Taniwaki M
Leuk Res; 2014 Jan; 38(1):103-8. PubMed ID: 23953881
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
[TBL] [Abstract][Full Text] [Related]
40. Development of an AlphaScreen assay for discovery of inhibitors of low-affinity glycan-lectin interactions.
Yegorova S; Chavaroche AE; Rodriguez MC; Minond D; Cudic M
Anal Biochem; 2013 Aug; 439(2):123-31. PubMed ID: 23685052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
